Chairman and CEO of Stryker Corp (SYK, Financial) Kevin Lobo sold 39,808 shares of SYK on 03/22/2018 at an average price of $162.9 a share. The total sale was $6.5 million.
Stryker Corp is engaged in designing, manufacturing and marketing of medical equipment, instruments, and implantable devices. Its products include hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, and spinal devices. Stryker Corp has a market cap of $58.79 billion; its shares were traded at around $157.57 with a P/E ratio of 58.80 and P/S ratio of 4.82. The dividend yield of Stryker Corp stocks is 1.12%. Stryker Corp had annual average EBITDA growth of 4.20% over the past ten years. GuruFocus rated Stryker Corp the business predictability rank of 3-star.
CEO Recent Trades:
- Chairman and CEO Kevin Lobo sold 39,808 shares of SYK stock on 03/22/2018 at the average price of $162.9. The price of the stock has decreased by 3.27% since.
Directors and Officers Recent Trades:
- VP, Comm. and Public Affairs Yin C Becker sold 3,848 shares of SYK stock on 03/22/2018 at the average price of $162.9. The price of the stock has decreased by 3.27% since.
- Group President David Floyd sold 55,119 shares of SYK stock on 03/15/2018 at the average price of $166.58. The price of the stock has decreased by 5.41% since.
- VP, Comm. and Public Affairs Yin C Becker sold 23,221 shares of SYK stock on 03/09/2018 at the average price of $165.96. The price of the stock has decreased by 5.06% since.
- VP, Strategy and IR Katherine Ann Owen sold 3,700 shares of SYK stock on 03/05/2018 at the average price of $161.66. The price of the stock has decreased by 2.53% since.
For the complete insider trading history of SYK, click here
.
